Literature DB >> 11222796

MS and neuromyelitis optica in Martinique (French West Indies).

P Cabre1, O Heinzlef, H Merle, G G Buisson, O Bera, R Bellance, J C Vernant, D Smadja.   

Abstract

BACKGROUND AND
OBJECTIVE: A population-based study is reported of MS in French Afro-Caribbeans (FAC) in Martinique. FAC are descendants of interracial mating that occurred between French Caucasians and black Africans in the 17th and the 18th centuries.
METHODS: The authors surveyed the entire island of Martinique (area 1,128 km(2), population 357,000) between November 1997 and October 1999.
RESULTS: Sixty-two patients (46 females, 16 males, ratio 2.9:1) were identified with definite or probable disease by the Poser criteria. Prevalence for all patients on December 31, 1998, was 17.4/10(5) (95% CI 13.1 to 21.7) and 14.3/10(5) (95% CI 10.4 to 18.2) for clinically definite cases (n = 51). Age range of patients on prevalence day was 17 to 73 years (mean +/- SD 39 +/- 11.3 years). Mean age at onset was 31.2 +/- 11 years. Overall, 9.7% had primary progressive disease and 19.4% had benign MS. A low proportion of definite and probable MS cases had oligoclonal bands in CSF (50.9%). Seventeen patients, 13 of whom were alive on prevalence day, had a relapsing form of neuromyelitis optica.
CONCLUSION: The island of Martinique appears to have a low to medium prevalence of MS. MS was almost unknown in FAC in Martinique until the late 1970s. The apparent recent increase may be explained by improved recognition of patients, increased availability of MRI for diagnosis, increased disease awareness among physicians, increased survival of MS patients, or an actual increase in disease frequency.

Entities:  

Mesh:

Year:  2001        PMID: 11222796     DOI: 10.1212/wnl.56.4.507

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 3.  Multiple Sclerosis in Latin Americans: Genetic Aspects.

Authors:  Victor M Rivera
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

4.  An epidemiological study of neuromyelitis optica in Cuba.

Authors:  Jose A Cabrera-Gómez; John F Kurtzke; Alina González-Quevedo; R Lara-Rodríguez
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

5.  Ward round: A patient with blurred vision and leg weakness.

Authors:  Mulinda Nyirenda; William Whiteley; Ed Zijlstra
Journal:  Malawi Med J       Date:  2007-06       Impact factor: 0.875

6.  Neuromyelitis Optica Spectrum Disorder in a Chinese Woman with Ocular Myasthenia Gravis: First Reported Case in the Chinese Population.

Authors:  Gordon S K Yau; Jacky W Y Lee; Theo T K Chan; Can Y F Yuen
Journal:  Neuroophthalmology       Date:  2014-04-02

Review 7.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

8.  The incidence and prevalence of neuromyelitis optica: a systematic review.

Authors:  Ruth Ann Marrie; Caroline Gryba
Journal:  Int J MS Care       Date:  2013

9.  Characteristics of Devic's disease (neuromyelitis optica) in Mexico.

Authors:  John Flores Rivera; John F Kurtzke; Vanessa J Alatriste Booth; Teresa Corona V
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

10.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.